UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 861177
NEW YORK, NY
Position in MDGL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$12,456,488
-$1,429,989 QoQ
Shares Held
23,796
-0.2% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 37.62397041519583.ToString("F0")%
Shared 0.ToString("F0")%
None 62.37602958480417.ToString("F0")%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. MDGL ranks #35 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in MDGL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,456,488 | 23,796 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $13,886,477 | 23,846 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $10,767,499 | 23,476 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,047,792 | 39,809 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,732,213 | 26,363 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $8,497,397 | 27,538 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,744,385 | 22,356 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,894,453 | 24,609 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,801,312 | 14,235 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,293,691 | 14,235 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,311,226 | 15,826 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,574,032 | 15,472 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,748,244 | 15,472 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $1,081,043 | 16,634 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,190,659 | 16,634 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,219,629 | 12,430 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,053,316 | 12,430 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $991,788 | 12,430 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,210,804 | 12,430 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,382,934 | 11,823 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,078,458 | 9,701 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $1,114,160 | 9,384 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $975,647 | 8,615 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $239,801 | 3,592 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||